ISIV-NASDAQ US BIOTE. DLA
ISIV-NASDAQ US BIOTE. DLA
ETF · IE00BYXG2H39 · A2DWAW (XDUB)
Overview
5,43 EUR
1,29 % 0,07 EUR
ISE (XETR) · Current prices and charts at MoneyPeak
06.06.2025 15:36

Current Prices from ISIV-NASDAQ US BIOTE. DLA

ExchangeTickerCurrencyLast TradePriceDaily Change
XETR: XETRA
XETRA
2B70.DE
EUR
06.06.2025 15:36
5,43 EUR
5,36 EUR
+1,29 %
XLON: London
London
BTEC.L
USD
06.06.2025 15:11
6,18 USD
6,12 USD
+1,02 %
XLON: London
London
BTEK.L
GBP
06.06.2025 14:55
4,56 GBP
4,48 GBP
+1,90 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 3,91 % 3,20 % -10,42 % -14,52 % -10,65 % 3,51 %
Asset Allocation
AssetPercentage %
Keine Daten vorhanden
Largest Positions
SymbolISINNamePercentage %
Keine Daten vorhanden
Region Distribution
RegionPercentage %
Keine Daten vorhanden
Sector Distribution
SectorPercentage %
Keine Daten vorhanden

Company Profile for ISIV-NASDAQ US BIOTE. DLA ETF

The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology Index.
Fund Master Data
Issuer iShares IV plc
Asset Class ETF
Name iShares Nasdaq US Biotechnology UCITS ETF
Reference Index Nasdaq Biotechnology Index(R)
Asset Class Aktien
Asset Subclass Small Caps
Fund Currency USD
Total Expense Ratio (TER) 0,35 %
Fund Domicile Vereinigte Staaten von Amerika
Region Nordamerika
Benchmark Index 1628.96
Distribution Type thesaurierend
Markets Industrieländer
fund.
Risk Indicator 6
Fund Key Figures
Fund Size 502.869,22 EUR
NAV 7.6
AUM 545,5 M EUR
Number of Shares 66196534
PE Ratio 29.5
PB Ratio 6.74
Sustainability
MSCI ESG Rating A
MSCI Index carbon footprint metrics 20.06
Investment Strategy
iShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF is an exchange traded fund launched by BlackRock Asset Management Ireland Limited. It is managed by BlackRock Advisors (UK) Limited. The fund invests in the public equity markets of the United States. It seeks to invest in the stocks of companies operating in the biotechnology and pharmaceuticals sector. The fund invests in the stocks of companies across all market capitalizations. It seeks to replicate the performance of the NASDAQ Biotechnology Index, by employing representative sampling methodology. iShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF was formed on October 19, 2017 and is domiciled in Ireland.

Company Data

Name ISIV-NASDAQ US BIOTE. DLA
Company iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Primary Exchange XDUB ISE
WKN A2DWAW
ISIN IE00BYXG2H39
Asset Class ETF
Sector Financial Services
Industry Asset Management
Market Capitalization 342 Mio
Country Ireland
Currency EUR
Employees -
IPO Date 2017-10-19

Ticker Symbols

Name Symbol
Frankfurt 2B70.F
London BTEC.L
London BTEK.L
XETRA 2B70.DE

More Shares

Investors who ISIV-NASDAQ US BIOTE. DLA hold also have the following shares in their portfolio:
AAREAL BANK AG
AAREAL BANK AG Share
ADVANCED MICRO DEVICES INC
ADVANCED MICRO DEVICES INC Share
AMAZON.CO INC
AMAZON.CO INC Share
APPLE INC
APPLE INC Share
CITIGROUP INC
CITIGROUP INC Share
FINNLD 20/36
FINNLD 20/36 Bond
FIRST ABU DHABI BK 17/22
FIRST ABU DHABI BK 17/22 Bond
ISHSII-GL.CL.ENERGY DLDIS
ISHSII-GL.CL.ENERGY DLDIS ETF
META PLATFORMS INC
META PLATFORMS INC Share
MICROSOFT CORP
MICROSOFT CORP Share
NVIDIA CORP
NVIDIA CORP Share
PALANTIR TECHNOLOGIESLOGIES INC CLASS A
PALANTIR TECHNOLOGIESLOGIES INC CLASS A Share
PAYPAL INC
PAYPAL INC Share
TESLA INC
TESLA INC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025